Lecture 13: Integration of Salt and Water balance Flashcards
ADH
= AVP = Arginine vasopressin
Function: Increased Water reabsoprtion into ICF/ECF –> concentrated urine + decreased flow
Location: DT + Collecting Tubule (+ collecting duct epithelia) –> Acts at end of circuit as is final bulk water changes
- allows for conservation of water during dehydration
Location of ADH release
ADH = Nonapeptide
Hypothalamus –> osmoreceptor, baroreceptor, cardiopulmonary receptor stimulation) stimulate Supraoptic and Paraventricular neuron –> release of synthesised precursor protein to Posterior Pituitary –> posterior pituitary storage granules situate at nerve terminals
What sort of peptide is ADH
Nonapeptide
Acute vs Chronic ADH release
Acute: Osmolality change 1. Osmoreceptors in hypothalamus Chronic: Blood Volume Change 1. Baroreceptors (change pressure) 2. Cardiopulmonary Volume receptors --> STRETCH of atrium and ventricles sensed
Sensitivity of osmoreceptor, baroreceptor and cardiopulmonary receptor to changes
ECF Osmolality change (acute): <1% change (lower threshold (starts earlier), higher sensitivity(quicker/steeper gradient))
ECF Blood Volume change (chronic): >10% change (longer period passes + slower increased release)
Physiological and Non physiological causes of ADH release
Physiological: 1. Increased plasma osmolality 2. Decreased ECF volume Non-Physiological: 1. Pain, stress 2. Drugs: narcotics, carbazapine, vincristine, chloropropamide, ifosfamise, nicotine, SSRI 3. Carcinomas (esp. small cell) 4. Pulmonary disorders 5. CNS disorders (6. Alcohol inhibits ADH secretion)
Inhibition of ADH secretion
ADH
Is the descending limb of LOH permeable to water?
Yes
To what extent can ADH reduce water loss
1L/hour 15mL/hour
SIADH
Syndrome of Inappropriate ADH release Increased plasma ADH --> inappropriate water retention ( -ve Free water clearance) --> significantly low osmolality (hypo-osmotic state) --> tasteless urine Causes: 1. Brain injury/tumour 2. Some anti cancer drugs 3. Lung cancer and some other cancers Treatment: Restricted water consumption --> decreased H2O input --> relatively less able to be retained
Central and Nephrogenic Diabetes insipidus
Low/absent ADH levels –> First sign: High urine volume
Central Diabetes Insipidus
Head Trauma/ brain injury/tumour/infection –> disruption of osmoreceptors –> Central DI –> changing osmolality but unable to produce ADH –> increased urine volume and decreased urine taste
- Rarely hereditary
- Treatment: ADH analogs
Nephrogenic Diabetes Insipidus
ADH release from posterior pituitary --> non-functional V2 receptor in kidney's nephron's CD/DT --> ADH unable to make any changes --> increased volume and diluteness of urine Causes: 1. Drugs (Lithium) 2. Hereditary (less common): - Congenital V2 defect Inherited AQP-2 defect No Treatment available
Test to differentiate between Central and Nephrogenic Diabetes Neuropathy
Water Deprivation Test
- give DDADH –> Increase in Central DI not nephrogenic
- grapht
ADH cellular mechanism
ADH binds to V2 receptor on distal tubule –> AQP2 receptor inserts into tubular lumen –> Water enters cell and is reabsorbed